Progyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) Price to free cash flow
As of 6 November 2026, Progyny, Inc. (PGNY) trades at a price to free cash flow of 14.8×. Over the past ten years it has ranged from 0.0× (March 2020) to 406× (April 2022); the current reading is higher than 38% of that period. That is in line with the Healthcare Plans industry median of 14.8× and below the Healthcare sector median of 20.5×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 11.5× | 34.59% |
| FY2024 | 8.5× | (55.37%) |
| FY2023 | 19.1× | (47.76%) |
| FY2022 | 36.6× | (80.52%) |
| FY2021 | 188× | 81.60% |
| FY2020 | 103× | — |
| FY2019 | 0.0× | — |
| FY2018 | 16.6× | 0.00% |
| FY2017 | 16.6× | — |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Sep 2026 | 10.7× | (15.39%) |
| Jun 2026 | 12.6× | 69.55% |
| Mar 2026 | 7.5× | (35.04%) |
| Dec 2025 | 11.5× | 19.87% |
| 28 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| OSCR Oscar Health, Inc. compare | 2.3× |
| CNC Centene Corporation compare | 8.7× |
| CI Cigna Group compare | 9.3× |
| ELV Elevance Health, Inc. compare | 14.2× |
| PGNY Progyny, Inc. | 14.8× |
| HUM Humana Inc. compare | 16.5× |
| CLOV Clover Health Investments, Corp. compare | 19.2× |
| ALHC Alignment Healthcare, Inc. compare | 19.8× |
| MOH Molina Healthcare, Inc compare | 44.8× |
| Healthcare Plans industry median | 14.8× |
| Healthcare sector median | 20.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on PGNY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement